Navigation Links
H1N1 pandemic points to vaccine strategy for multiple flu strains
Date:1/10/2011

"

When the study began, there was no vaccine for the novel 2009 H1N1 strain. The researchers hoped to use the antibodies from patients who recovered as therapy for those who were severely ill with this emerging virus.

The researchers began by analyzing antibody responses from nine patients recruited through the Hope Clinic, the clinical division of the Emory Vaccine Center. In these patients, ages 21 to 45 years old, the virus caused a range of illness, from mild to life-threatening disease.

The researchers identified white blood cells from the patients that made antibodies against the virus, then isolated antibody genes from individual cells. They used the genes to produce antibodiesa total of 86 varietiesand then tested which flu strains the antibodies reacted against.

Five antibodies isolated by the team could bind all the seasonal H1N1 flu strains from the last decade, the devastating "Spanish flu" strain from 1918, plus a potentially lethal H5N1 avian flu strain.

This indicated that "while the flu changes from year to year, some core elements have been consistent for nearly a century," said Wilson.

The cross-reactive antibodies were produced by highly mutated antibody genes. These antibodies appear to have been produced by white blood cells that had been exposed to influenza in previous years and were reactivated by a new viral infection. As the antibody genes, developed to combat one strain, adapted to a new infection, they continued to mutate, increasing their affinity for certain key targets present on both strains.

Half of the cross-reactive antibodies the team identified attached to the virus's "stalk" region, a sort of biochemical drill-bit the virus uses to enter cells. Because this part of the virus doesn't change as much as other regions, scientists have proposed to make it the basis for a vaccine that could provide broader protection.

"Previously, this type of broadly protective
'/>"/>

Contact: John Easton
john.easton@uchospitals.edu
773-702-6241
University of Chicago Medical Center
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Rethinking who should be considered essential during a pandemic flu outbreak
2. Global Viral Forecasting Initiative receives $11M to implement pandemic early warning system
3. New World post-pandemic reforestation helped start Little Ice Age, say Stanford scientists
4. Swine flu genes dissimilar to past pandemics
5. 1 in 6 health workers wont report in flu pandemic -- study by Ben-Gurion U. researchers
6. K-State researcher, collaborators study virulence of pandemic H1N1 virus
7. Pandemic flu can infect cells deep in the lungs, says new research
8. Excellence in Paediatrics conference line-up includes WHO and CDC pandemic speakers
9. £7.5 million ($12.6 million) collaborations lead UK research communitys response to H1N1 pandemic
10. Short-term school closures may worsen flu pandemics, Pitt study finds
11. UT Southwestern scientist begins to unravel what makes pandemic H1N1 tick
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... "molecular brakes" that time the generation of important cells ... cells" translate sound waves into electrical signals that are ... If the arrangement of the cells is disordered, hearing ... will be published in The Journal of Neuroscience ... Hey2 act as brakes to prevent hair cell generation ...
(Date:9/16/2014)... take up residence in and on the human body ... according to new research at Washington University School of ... individuals carry about five types of viruses on their ... Biology . The study is the first comprehensive analysis ... , The research was conducted as part of ...
(Date:9/16/2014)... 66 million years ago, a 10-km diameter chunk of rock ... town of Chicxulub with the force of 100 teratons of ... and the resulting megatsunami, wildfires, global earthquakes and volcanism are ... way for the rise of the mammals. But what happened ... new study led by researchers from the University of Arizona ...
Breaking Biology News(10 mins):Hey1 and Hey2 ensure inner ear 'hair cells' are made at the right time, in the right place 2Healthy humans make nice homes for viruses 2Healthy humans make nice homes for viruses 3Meteorite that doomed the dinosaurs helped the forests bloom 2Meteorite that doomed the dinosaurs helped the forests bloom 3
... a new biological pathway-based computational model, called the Pathway-based ... between different diseases as reported in BioDataMining ... present in large publicly available disease datasets to find ... a visual form. "The PHPN offers a bird,s ...
... 11 million people suffer severe burns. The resulting large, deep ... lifelong scars. What is needed to reduce this kind of ... very limited area of skin can be removed from the ... Besides conventional skin grafting, another option is to engineer a ...
... to finding cures for heart disease scientists are working to ... a tissue model for the human heart that can bridge ... exist for other organs, but for the heart, this has ... embryonic stem cells with the resulting muscle having significant similarities ...
Cached Biology News:Dartmouth researchers develop new tool to identify genetic risk factors 2Blood and lymphatic capillaries grown for the first time in the lab 2Scientists develop an engineered cardiac tissue model to study the human heart 2
(Date:9/18/2014)... NY (PRWEB) September 18, 2014 Whitehouse ... negotiations with Salem Realty Group and has acquired an ... space within the Salem Executive Complex adjacent to its ... was held on Friday September 5th. Whitehouse Labs is ... the entire space specifically for package testing. The prime ...
(Date:9/17/2014)... Sept. 17, 2014 /PRNewswire/ - Oncothyreon Inc. (NASDAQ: ... offer and sell shares of its Common Stock and ... underwritten public offerings.  The Series A Convertible Preferred Stock ... Stock, provided that conversion will be prohibited if, as ... own more than 4.99% of the Common Stock then ...
(Date:9/17/2014)... , Sept. 17, 2014  MiMedx Group, Inc. (NASDAQ: ... and marketer of patent protected regenerative biomaterials and ... publication of another peer-reviewed clinical study.    ... Multi-center Randomized Controlled Clinical Trial Evaluating the Use ... Allografts and Multi-layer Compression Therapy vs. Multi-layer Compression ...
(Date:9/17/2014)... 17, 2014 Immunomic Therapeutics, Inc. announced ... (SBIR) grant to support the continued preclinical development of ... with approximately $255,000 over one year to conduct vaccine ... food allergy, affect over one million Americans and are ... Tree nut exposure is also a risk for peanut ...
Breaking Biology Technology:Whitehouse Labs Announces Package Testing Laboratory Expansion 2Whitehouse Labs Announces Package Testing Laboratory Expansion 3Whitehouse Labs Announces Package Testing Laboratory Expansion 4Oncothyreon Announces Proposed Public Offerings 2MiMedx Multi-Center Randomized, Controlled VLU Clinical Study Published In Peer-Reviewed Journal 2MiMedx Multi-Center Randomized, Controlled VLU Clinical Study Published In Peer-Reviewed Journal 3MiMedx Multi-Center Randomized, Controlled VLU Clinical Study Published In Peer-Reviewed Journal 4Immunomic Therapeutics Awarded SBIR Grant to Develop Multi-Nut Allergy Immunotherapy 2Immunomic Therapeutics Awarded SBIR Grant to Develop Multi-Nut Allergy Immunotherapy 3
... ROMAINVILLE, France, March 13 ,Cellectis SA (NYSE: ... rational genome engineering,has announced today that it ... Inc. in the United States District Court ... lawsuit seeks a declaration that,by making and ...
... pm ET today, BEDMINSTER, N.J., March 13 ... reported 2007 financial results,and accomplishments that reflected the ... late-stage product candidates in specialty,indications for gastrointestinal and ... line with its new business plan, during 2007 ...
... IV Patent Challenge Underway -, CORONA, Calif., ... ), a leading specialty pharmaceutical,company, today confirmed that ... with the U.S. Food and Drug Administration (FDA) ... tablets, USP,(0.09 mg/0.02 mg) extended-cycle oral contraceptive product ...
Cached Biology Technology:Cellectis Sues Precision BioSciences for Infringement of its Patents Concerning Meganuclease Technology 2Cellectis Sues Precision BioSciences for Infringement of its Patents Concerning Meganuclease Technology 3Cellectis Sues Precision BioSciences for Infringement of its Patents Concerning Meganuclease Technology 4NPS Pharmaceuticals Reports 2007 Financial Results 2NPS Pharmaceuticals Reports 2007 Financial Results 3NPS Pharmaceuticals Reports 2007 Financial Results 4NPS Pharmaceuticals Reports 2007 Financial Results 5NPS Pharmaceuticals Reports 2007 Financial Results 6NPS Pharmaceuticals Reports 2007 Financial Results 7NPS Pharmaceuticals Reports 2007 Financial Results 8NPS Pharmaceuticals Reports 2007 Financial Results 9Watson Files FDA Application for Generic LYBREL(R) 2
... PCR Purification Kits provide rapid and efficient ... PCR products, and salts from PCR products ... provides two Binding Buffer options for ... can be performed in either single column ...
Mus musculus junctophilin 2 (Jph2) Antigen: Recombinant Protein...
... Cloning Kits for Sequencing allow 5-minute cloning and ... TOPO Cloning vectors with primer sites located as ... product insertion site. This minimizes the amount of ... reaching the sequence of your insert.vectors are available. ...
2.0 GHz Compaq Computer with 512 MB RAM, 32 MB AGP Graphics Card, 40 GB Hard Drive, 1 Serial Port & Open PCI Slot, Windows 2000 OS, MS Office, CD Read/Writer and 18 Flat Panel Monitor...
Biology Products: